First Ascent Biomedical is validating a live-cell testing platform that screens over 150 FDA-approved therapies against a patient’s tumor, generating individualized treatment insights in about 10 days.
Read More
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.
Read More
The collaboration will provide automated narrative summaries and biomarker insights to reduce interpretation workload across laboratory disciplines.
Read More
The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read More
The proteomics company will use capital to advance partner-driven product development and commercial operations from new California headquarters.
Read More